Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted oral protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders.

Dunad Therapeutics

Pearl Huang

Elayne Penebre

Laura Donehue

Kathryn McNaughton

Holly Whittemore

The Biology Team at Dunad Therapeutics conducts cutting-edge research to identify and validate therapeutic targets for next-generation oral protein degradation therapies. They are responsible for developing and optimizing biological assays, characterizing the molecular mechanisms of target degradation, and evaluating the efficacy and specificity of tunable mono-valent small molecules in preclinical models.

Biology Team

The Leadership Team at Dunad Therapeutics is responsible for driving the strategic direction and overall management of the company. This team oversees the company's operations, scientific research, business development, and program management to advance the development of next-generation targeted oral protein degradation therapies. They ensure alignment across various functions to achieve corporate goals and maintain regulatory and financial compliance.

Dunad Therapeutics

Org chart

Teams

Biology Team

Leadership Team

Offices

Dunad Therapeutics

Org chart

Teams

Biology Team

Leadership Team

Offices

Related companies